TipRanks
InfuSystem Holdings, Inc. (DE:1TZ)
FRANKFURT:1TZ
Germany Market

InfuSystem Holdings (1TZ) Ratios

1 Followers

InfuSystem Holdings Ratios

DE:1TZ's free cash flow for Q2 2026 was $0.58. For the 2026 fiscal year, DE:1TZ's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.50 1.80 1.82 1.95 1.71
Quick Ratio
2.14 1.53 1.45 1.54 1.38
Cash Ratio
0.06 0.16 0.03 0.01 0.01
Solvency Ratio
0.48 0.46 0.32 0.26 0.26
Operating Cash Flow Ratio
1.53 1.21 1.16 0.71 1.21
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -282.00K$ -6.90M$ -13.92M$ -19.99M$ -26.61M
Leverage Ratios
Debt-to-Assets Ratio
0.24 0.03 0.27 0.34 0.37
Debt-to-Equity Ratio
0.39 0.06 0.49 0.67 0.77
Debt-to-Capital Ratio
0.28 0.06 0.33 0.40 0.43
Long-Term Debt-to-Capital Ratio
0.26 0.06 0.29 0.36 0.41
Financial Leverage Ratio
1.65 1.75 1.80 1.97 2.07
Debt Service Coverage Ratio
26.53 16.34 9.74 7.17 10.54
Interest Coverage Ratio
18.38 9.18 3.88 1.88 1.18
Debt to Market Cap
0.08 0.02 0.13 0.13 0.18
Interest Debt Per Share
1.19 0.23 1.42 1.76 1.86
Net Debt to EBITDA
0.98 <0.01 1.39 2.10 2.47
Profitability Margins
Gross Profit Margin
57.45%55.98%52.20%50.17%55.10%
EBIT Margin
9.02%8.31%5.58%3.20%1.39%
EBITDA Margin
15.92%17.58%14.85%13.14%13.55%
Operating Profit Margin
9.26%8.31%5.11%3.25%1.50%
Pretax Profit Margin
8.52%7.41%3.75%1.47%0.12%
Net Profit Margin
5.96%4.62%1.74%0.69%0.02%
Continuous Operations Profit Margin
5.96%4.62%1.74%0.69%0.02%
Net Income Per EBT
69.96%62.38%46.35%47.11%13.85%
EBT Per EBIT
92.05%89.12%73.41%45.28%7.86%
Return on Assets (ROA)
8.74%6.59%2.26%0.85%0.02%
Return on Equity (ROE)
14.81%11.56%4.08%1.67%0.04%
Return on Capital Employed (ROCE)
16.10%14.83%8.02%4.69%1.95%
Return on Invested Capital (ROIC)
11.26%9.25%3.72%2.21%0.27%
Return on Tangible Assets
9.76%7.36%2.51%0.95%0.02%
Earnings Yield
3.40%3.58%1.30%0.39%0.01%
Efficiency Ratios
Receivables Turnover
5.27 6.26 6.37 6.34 6.51
Payables Turnover
6.79 5.83 6.55 7.83 5.92
Inventory Turnover
11.05 11.71 9.87 9.79 10.24
Fixed Asset Turnover
21.98 19.03 14.34 2.74 2.29
Asset Turnover
1.47 1.43 1.30 1.22 1.11
Working Capital Turnover Ratio
6.75 9.36 9.17 9.98 11.28
Cash Conversion Cycle
48.57 26.89 38.46 48.18 29.99
Days of Sales Outstanding
69.28 58.28 57.26 57.54 56.02
Days of Inventory Outstanding
33.03 31.16 36.97 37.28 35.65
Days of Payables Outstanding
53.74 62.55 55.77 46.64 61.69
Operating Cycle
102.31 89.44 94.22 94.82 91.68
Cash Flow Ratios
Operating Cash Flow Per Share
1.16 1.18 0.96 0.53 0.85
Free Cash Flow Per Share
0.95 0.76 0.12 <0.01 0.12
CapEx Per Share
0.21 0.42 0.84 0.53 0.73
Free Cash Flow to Operating Cash Flow
0.82 0.64 0.13 <0.01 0.14
Dividend Paid and CapEx Coverage Ratio
5.47 2.81 1.15 1.01 1.16
Capital Expenditure Coverage Ratio
5.47 2.81 1.15 1.01 1.16
Operating Cash Flow Coverage Ratio
1.00 7.12 0.72 0.32 0.47
Operating Cash Flow to Sales Ratio
0.16 0.17 0.15 0.09 0.16
Free Cash Flow Yield
7.58%8.48%1.46%0.05%1.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
29.69 28.03 76.82 254.12 9.96K
Price-to-Sales (P/S) Ratio
1.76 1.29 1.33 1.76 1.63
Price-to-Book (P/B) Ratio
4.25 3.23 3.12 4.24 3.73
Price-to-Free Cash Flow (P/FCF) Ratio
13.19 11.79 68.45 2.09K 73.43
Price-to-Operating Cash Flow Ratio
10.76 7.59 8.79 19.74 10.23
Price-to-Earnings Growth (PEG) Ratio
0.36 0.15 0.44 0.06 -100.87
Price-to-Fair Value
4.25 3.23 3.12 4.24 3.73
Enterprise Value Multiple
12.01 7.36 10.37 15.50 14.50
Enterprise Value
274.16M 185.54M 207.64M 256.27M 215.98M
EV to EBITDA
12.01 7.36 10.37 15.50 14.50
EV to Sales
1.91 1.29 1.54 2.04 1.97
EV to Free Cash Flow
14.36 11.80 79.07 2.42K 88.48
EV to Operating Cash Flow
11.73 7.60 10.15 22.83 12.33
Tangible Book Value Per Share
2.43 2.26 2.23 1.96 1.74
Shareholders’ Equity Per Share
2.94 2.78 2.70 2.49 2.32
Tax and Other Ratios
Effective Tax Rate
0.30 0.38 0.54 0.53 0.86
Revenue Per Share
7.12 6.94 6.34 5.98 5.32
Net Income Per Share
0.42 0.32 0.11 0.04 <0.01
Tax Burden
0.70 0.62 0.46 0.47 0.14
Interest Burden
0.94 0.89 0.67 0.46 0.08
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.48 0.47 0.46 0.36 0.40
Stock-Based Compensation to Revenue
0.04 0.03 0.03 0.03 0.03
Income Quality
2.74 3.68 8.72 12.87 973.17
Currency in USD